Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 54.18-2.417.3270.7146.60

What is the latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EBIT Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 54.18 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202554.18
Mar2024-2.41
Mar20237.32
Mar202270.71
Mar202146.60

How is EBIT Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 54.18
Positive
Mar2024 -2.41
Negative
Mar2023 7.32
-89.65
Mar2022 70.71
51.74
Mar2021 46.6 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹53,499.1 Cr 0.1% -4.2% 18.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,219.0 Cr 0.4% 1.7% 2% Stock Analytics
DIVIS LABORATORIES ₹175,227.0 Cr -0.3% -3.8% 35.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,643.0 Cr 3.9% 11.8% 20% Stock Analytics
CIPLA ₹125,541.0 Cr 1.5% 3.8% 2% Stock Analytics
DR REDDYS LABORATORIES ₹106,063.0 Cr -0.5% -0.1% -5.1% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

0.1%

-4.2%

18.2%

SENSEX

-1.2%

-3%

-0.2%


You may also like the below Video Courses